Related references
Note: Only part of the references are listed.Therapeutic targets in myeloma bone disease
Silvia Marino et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
ARRIVE 2.0 and the British Journal of Pharmacology: Updated guidance for 2020
Elliott Lilley et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research
Nathalie Percie du Sert et al.
PLOS BIOLOGY (2020)
Adipocyte and lipid metabolism in cancer drug resistance
Yihai Cao
JOURNAL OF CLINICAL INVESTIGATION (2019)
Chemically Modified Variants of Fenofibrate with Antiglioblastoma Potential
J. Stalinska et al.
TRANSLATIONAL ONCOLOGY (2019)
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Enzymes
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Structural basis for the activation and inhibition of Sirtuin 6 by quercetin and its derivatives
Weijie You et al.
SCIENTIFIC REPORTS (2019)
Multiple Myeloma and Fatty Acid Metabolism
Majdi Masarwi et al.
JBMR PLUS (2019)
A metabolic switch in proteasome inhibitor-resistant multiple myeloma ensures higher mitochondrial metabolism, protein folding and sphingomyelin synthesis
Lenka Besse et al.
HAEMATOLOGICA (2019)
Goals and practicalities of immunoblotting and immunohistochemistry: A guide for submission to the British Journal of Pharmacology
Steve P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers
Michael J. Curtis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
New links between lipid accumulation and cancer progression
Joseph T. Nickels
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Extracellular vesicles: lipids as key components of their biogenesis and functions
Michel Record et al.
JOURNAL OF LIPID RESEARCH (2018)
Association of tamoxifen resistance and lipid reprogramming in breast cancer
Susanne Hultsch et al.
BMC CANCER (2018)
Lipidomic profiling of extracellular vesicles derived from prostate and prostate cancer cell lines
Joshua S. Brzozowski et al.
LIPIDS IN HEALTH AND DISEASE (2018)
Fatostatin induces pro- and anti-apoptotic lipid accumulation in breast cancer
Viktor Brovkovych et al.
ONCOGENESIS (2018)
SREBP-1a-stimulated lipid synthesis is required for macrophage phagocytosis downstream of TLR4-directed mTORC1
Jae-Ho Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Lipid metabolism reprogramming and its potential targets in cancer
Chunming Cheng et al.
CANCER COMMUNICATIONS (2018)
Compensatory RNA polymerase 2 loading determines the efficacy and transcriptional selectivity of JQ1 in Myc-driven tumors
E. Donato et al.
LEUKEMIA (2017)
Statin use and risk of multiple myeloma: An analysis from the cancer research network
Mara M. Epstein et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology
Hitoshi Shimano et al.
NATURE REVIEWS ENDOCRINOLOGY (2017)
An Overview of Lipid Droplets in Cancer and Cancer Stem Cells
L. Tirinato et al.
STEM CELLS INTERNATIONAL (2017)
ATF4 overexpression induces early onset of hyperlipidaemia and hepatic steatosis and enhances adipogenesis in zebrafish
Kun-Yun Yeh et al.
SCIENTIFIC REPORTS (2017)
De Novo Lipid Synthesis Facilitates Gemcitabine Resistance through Endoplasmic Reticulum Stress in Pancreatic Cancer
Saber Tadros et al.
CANCER RESEARCH (2017)
In Vitro Apoptosis Induction by Fenofibrate in Lymphoma and Multiple Myeloma
Leonard Christopher Schmeel et al.
ANTICANCER RESEARCH (2017)
Targeting lipid metabolism of cancer cells: A promising therapeutic strategy for cancer
Qiuping Liu et al.
CANCER LETTERS (2017)
Cyclin E Associates with the Lipogenic Enzyme ATP-Citrate Lyase to Enable Malignant Growth of Breast Cancer Cells
Kimberly S. Lucenay et al.
CANCER RESEARCH (2016)
Statins Are Associated With Reduced Mortality in Multiple Myeloma
Kristen Marie Sanfilippo et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Thematic Review Series: Lipotoxicity: Many Roads to Cell Dysfunction and Cell Death The role of ER stress in lipid metabolism and lipotoxicity
Jaeseok Han et al.
JOURNAL OF LIPID RESEARCH (2016)
Lipid metabolic reprogramming in cancer cells
S. Beloribi-Djefaflia et al.
ONCOGENESIS (2016)
Targeting Phospholipid Metabolism in Cancer
Menglin Cheng et al.
FRONTIERS IN ONCOLOGY (2016)
Up-regulation of fatty acid synthase induced by EGFR/ERK activation promotes tumor growth in pancreatic cancer
Yong Bian et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
SREBP maintains lipid biosynthesis and viability of cancer cells under lipid- and oxygen-deprived conditions and defines a gene signature associated with poor survival in glioblastoma multiforme
C. A. Lewis et al.
ONCOGENE (2015)
Hypoxia induces triglycerides accumulation in prostate cancer cells and extracellular vesicles supporting growth and invasiveness following reoxygenation
Isabel R. Schlaepfer et al.
ONCOTARGET (2015)
Fenofibrate induces apoptosis of triple-negative breast cancer cells via activation of NF-κB pathway
Ting Li et al.
BMC CANCER (2014)
Immunoglobulin free light chains and GAGs mediate multiple myeloma extracellular vesicles uptake and secondary NfκB nuclear translocation
Giuseppe Di Noto et al.
FRONTIERS IN IMMUNOLOGY (2014)
ATF4 Protein Deficiency Protects against High Fructose-induced Hypertriglyceridemia in Mice
Guozhi Xiao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Effects of fenofibrate on cardiovascular events in patients with diabetes, with and without prior cardiovascular disease: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
Andrew Tonkin et al.
AMERICAN HEART JOURNAL (2012)
In vitro stability and in vivo anti-inflammatory efficacy of synthetic jasmonates
Hung The Dang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
Activation of ATF4 mediates unwanted Mcl-1 accumulation by proteasome inhibition
Jinsong Hu et al.
BLOOD (2012)
Inhibition of Fatty Acid Metabolism Reduces Human Myeloma Cells Proliferation
Jose Manuel Tirado-Velez et al.
PLOS ONE (2012)
Isoprenoid biosynthetic pathway inhibition disrupts monoclonal protein secretion and induces the unfolded protein response pathway in multiple myeloma cells
Sarah A. Holstein et al.
LEUKEMIA RESEARCH (2011)
Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress
Ira Tabas et al.
NATURE CELL BIOLOGY (2011)
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
Kristin M. Nieman et al.
NATURE MEDICINE (2011)
Metabolite extraction from suspension-cultured mammalian cells for global metabolite profiling
Christopher A. Sellick et al.
NATURE PROTOCOLS (2011)
Fenofibrate induces effective apoptosis in mantle cell lymphoma by inhibiting the TNFα/NF-κB signaling axis
Z. Zak et al.
LEUKEMIA (2010)
Lipid raft-targeted therapy in multiple myeloma
F. Mollinedo et al.
ONCOGENE (2010)
Managing and exploiting stress in the antibody factory
Simone Cenci et al.
FEBS LETTERS (2007)
Determinants of sensitivity to lovastatin-induced apoptosis in multiple myeloma
W. Wei-Lynn Wong et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Fenofibrate - A review of its use in primary dyslipidaemia, the metabolic syndrome and type 2 diabetes mellitus
Gillian M. Keating et al.
DRUGS (2007)
Lovastatin and thalidomide have a combined effect on the rate of multiple myeloma cell apoptosis in short term cell cultures
A Dmoszynska et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Fenofibrate: a novel formulation (Triglide (TM)) in the treatment of lipid disorders: a review
Konstantinos Tziomalos et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2006)
Share Paper
